Vanda Pharmaceuticals (VNDA) Current Deferred Tax Assets (2010 - 2011)
Vanda Pharmaceuticals' (VNDA) quarterly Current Deferred Tax Assets came in at $182000.0 in Q3 2011, little changed quarter-over-quarter from $182000.0 in Q2 2011.
Vanda Pharmaceuticals (VNDA) Current Deferred Tax Assets (2010 - 2011) Analysis & Trends
Vanda Pharmaceuticals has disclosed Current Deferred Tax Assets across 2 years of filings, most recently posting $182000.0 for Q3 2011.
- Current Deferred Tax Assets for Q3 2011 came in at $182000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2011 was $182000.0 (changed N/A YoY), and the FY2010 annual result was $182000.0, changed N/A from the prior year.
- Current Deferred Tax Assets came in at $182000.0 for Q3 2011 at Vanda Pharmaceuticals, roughly flat from $182000.0 in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $182000.0 in Q4 2010 to a low of $182000.0 in Q4 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vanda Pharmaceuticals | 345.46 Mn | 143.15 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 182,000.00 |
| Sep 30, 2011 | 182,000.00 |
| Jun 30, 2011 | 182,000.00 |
| Jun 30, 2011 | 182,000.00 |
| Dec 31, 2010 | 182,000.00 |
| Dec 31, 2010 | 182,000.00 |